As Pony AI Inc. slashes hardware costs by 70% and plans a major fleet expansion, investors are weighing its potential as a high-stakes bet on the future of self-driving cars in key Asian markets.
Amidst a challenging macro landscape, telecom operator VEON Ltd. is posting robust growth in its core frontier markets while aggressively expanding its digital ecosystem. With a valuation significantly below peers, analysts are debating whether the market is overlooking a hidden gem or rightly pricing in geopolitical risks.
Gold prices soared to a historic peak above $5,500 an ounce this week, fueled by Fed policy signals, only to plunge dramatically as a resurgent U.S. Dollar and profit-taking sparked a broad retreat. The volatile swing sets a tense stage for the metal as markets await key economic data.
Realtor.com ranks the Florida Keys among the nation's top luxury markets, where strict development limits and finite land create a high-stakes arena for elite buyers seeking a unique legacy, not just a second home.
Tradeweb Markets launches integrated multi-asset package trading for USD-denominated swaps, aiming to streamline complex institutional workflows and deepen its foothold in the competitive electronic fixed income arena.
Analyst firm Argus has raised its price target for Sanmina Corporation (SANM) to $200, maintaining a Buy rating following the company's better-than-expected Q1 2026 results and robust positioning in key growth markets.
A dramatic reversal in precious metals markets saw silver crash 35% and gold fall 12% in a single session, testing a long-held crypto theory about capital rotation as Bitcoin demonstrates relative stability.
While market attention remains fixated on tech giants, the Russell 2000 index harbors promising, lesser-known companies. We examine three firms with distinct competitive advantages in environmental services, digital health, and private markets.
While low-volatility stocks offer a haven in turbulent markets, their perceived safety can sometimes obscure underlying financial weaknesses. We examine three such stocks where calm trading patterns may not justify their current valuations or growth prospects.
A blistering rally in gold and silver reversed violently on Friday, with prices plummeting in one of the most severe single-day drops in decades, rattling markets and investors.
Franklin Resources Inc. (NYSE: BEN) posted a robust fourth-quarter performance, with revenue soaring 38.3% year-over-year to $2.33 billion and adjusted EPS of $0.70, significantly exceeding analyst forecasts. The results were driven by positive net inflows across public and private markets.
Standex International reports robust second-quarter results, with organic growth reaching 6.4% and record quarterly orders. The company's strategic pivot towards high-growth markets like electrical grid infrastructure and new product development is now materially boosting the top line.
Standex International reports a robust start to fiscal 2026, with sales climbing 27.6% and a record order book prompting an upward revision of its annual revenue forecast. The company's strategic pivot towards grid modernization and data center markets, highlighted by the rebranded 'Standex Electronics Grid' unit, fuels confidence in exceeding long-term targets.
Standex International reported resilient Q1 2025 earnings with record gross margins above 40%, while announcing a transformative $462 million acquisition of Amran/Narayan Group, a leader in instrument transformers, aiming to double its exposure to fast-growing electrical infrastructure markets.
Thermo Fisher Scientific posted stronger-than-expected Q4 revenue and profit, driven by new products and strategic deals. However, the stock fell as investors weighed pressures in key academic and government markets against the company's solid 2026 outlook.
KeyBanc Capital Markets has upgraded LivaNova PLC (LIVN) from Sector Weight to Overweight, setting an $81 price target. The move reflects a broader positive shift in analyst sentiment towards the medical technology sector as valuation premiums ease.
Analyst Matthew O'Brien reaffirms an Overweight rating and $420 price target for Stryker, highlighting the potential of its new Mako RPS handheld orthopedic robot to capture cost-sensitive markets and compete with rivals like Zimmer Biomet.
The world's largest payment networks are taking a measured approach to stablecoins for everyday consumer transactions, citing a lack of clear demand in developed markets and emphasizing their role as infrastructure providers rather than disruptors.
Cavco Industries reports robust fiscal Q2 2026 earnings, with revenue up 9.7% year-over-year, driven by double-digit shipment growth in Northern U.S. markets. The company successfully managed a slowdown in the Southeast through operational adjustments and highlighted a significant turnaround in its financial services segment.
As the Bank of Canada signals a hold on interest rates, a backdrop of market stability is emerging. This analysis delves into three Canadian penny stocks—Britannia Life Sciences, ROK Resources, and Vision Lithium—that present distinct risk-reward profiles for investors eyeing the junior markets in early 2026.
